Velcera leading product, PetArmor flea and tick treatment, had over $100 million in US retail sales in 2012.
Perrigo Company (Nasdaq:PRGO; TASE:PRGO) yesterday completed the $160 million acquisition of US pet health company Velcera Inc.
Velcera and its FidoPharm subsidiary is best known for its flea and tick treatment PetArmor, which is the leading generic version of Frontline Top Spot, containing vets' most recommended active ingredient for flea and tick protection. Perrigo added that PetAmor, launched in April 2011, had over $100 million in retail sales in 2012
Perrigo added the PetArmor franchise brand will continue to enjoy the same broad distribution at retailers across the US.
Published by Globes [online], Israel business news - www.globes-online.com - on April 2, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013